Show simple item record

dc.contributor.authorParker, Aen_US
dc.contributor.authorKnapp, Pen_US
dc.contributor.authorTreweek, Sen_US
dc.contributor.authorMadhurasinghe, Ven_US
dc.contributor.authorLittleford, Ren_US
dc.contributor.authorGallant, Sen_US
dc.contributor.authorSullivan, Fen_US
dc.contributor.authorSchembri, Sen_US
dc.contributor.authorRick, Jen_US
dc.contributor.authorGraffy, Jen_US
dc.contributor.authorCollier, DJen_US
dc.contributor.authorEldridge, Sen_US
dc.contributor.authorKennedy, Aen_US
dc.contributor.authorBower, Pen_US
dc.date.accessioned2018-09-24T10:00:23Z
dc.date.available2018-08-31en_US
dc.date.issued2018-09-18en_US
dc.date.submitted2018-09-20T14:06:42.220Z
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/45043
dc.description.abstractBACKGROUND: Written participant information materials are important for ensuring that potential trial participants receive necessary information so that they can provide informed consent. However, such materials are frequently long and complex, which may negatively impact patient understanding and willingness to participate. Improving readability, ease of comprehension and presentation may assist with improved participant recruitment. The Systematic Techniques for Assisting Recruitment to Trials (MRC START) study aimed to develop and evaluate interventions to improve trial recruitment. This study aimed to assess the effectiveness of an optimised participant information brochure and cover letter developed by MRC START regarding response and participant recruitment rates. METHODS: We conducted a study within a trial (SWAT) embedded in the EarlyCDT Lung Cancer Scotland (ECLS) trial that aimed to assess the effectiveness of a new test in reducing the incidence of patients with late-stage lung cancer at diagnosis compared with standard care. Potential participants approached for ECLS were randomised to receive the original participant information brochure and accompanying letter (control group) or optimised versions of these materials which had undergone user testing and a process of re-writing, re-organisation and professional graphic design (intervention group). The primary outcome was the number of patients recruited to ECLS. The secondary outcome was the proportion of patients expressing an interest in participating in ECLS. RESULTS: In total, 2262 patients were randomised, 1136 of whom were sent the intervention materials and 1126 of whom were sent the control materials. The proportion of patients enrolled and randomised into ECLS was 180 of 1136 (15.8%) in the intervention group and 176 of 1126 (15.6%) in the control group (OR = 1.016, 95% CI, 0.660 to 1.564). The proportion of patients who positively responded to the invitation was 224 of 1136 (19.7%) in the intervention group and 205 of 1126 (18.2%) in the control group (OR = 1.103, 95% CI, 0.778 to 1.565). CONCLUSIONS: Optimised patient information materials made little difference to the proportion of patients positively responding to a trial invitation or to the proportion subsequently randomised to the host trial. TRIAL REGISTRATION: ClinicalTrials.gov, NCT01925625 . Registered on 15 August 2015. Study Within A Trial, SWAT-23. Registered on 12 April 2016.en_US
dc.description.sponsorshipThe ECLS trial is funded by the Chief Scientist Office of the Scottish Government and Oncimmune Ltd. The MRC START programme is funded by the MRC Methodology Research Programme (grant reference G1002325). The Health Services Research Unit, University of Aberdeen, receives core funding from the Chief Scientist Office of the Scottish Government Health Directorates.en_US
dc.format.extent503 - ?en_US
dc.languageengen_US
dc.language.isoenen_US
dc.relation.ispartofTrialsen_US
dc.rightsThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
dc.subjectPatient informationen_US
dc.subjectRandomised controlled trialen_US
dc.subjectRecruitmenten_US
dc.subjectResearch methodologyen_US
dc.subjectStudy within a trial (SWAT)en_US
dc.subjectAgeden_US
dc.subjectAutoantibodiesen_US
dc.subjectBiomarkers, Tumoren_US
dc.subjectComprehensionen_US
dc.subjectCorrespondence as Topicen_US
dc.subjectEarly Detection of Canceren_US
dc.subjectFemaleen_US
dc.subjectHealth Knowledge, Attitudes, Practiceen_US
dc.subjectHumansen_US
dc.subjectIncidenceen_US
dc.subjectLung Neoplasmsen_US
dc.subjectMaleen_US
dc.subjectMiddle Ageden_US
dc.subjectNeoplasm Stagingen_US
dc.subjectPamphletsen_US
dc.subjectPatient Education as Topicen_US
dc.subjectPatient Selectionen_US
dc.subjectPredictive Value of Testsen_US
dc.subjectResearch Subjectsen_US
dc.subjectSample Sizeen_US
dc.subjectScotlanden_US
dc.titleThe effect of optimised patient information materials on recruitment in a lung cancer screening trial: an embedded randomised recruitment trial.en_US
dc.typeArticle
dc.rights.holder© The Author(s). 2018.
dc.identifier.doi10.1186/s13063-018-2896-9en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/30227890en_US
pubs.issue1en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
pubs.volume19en_US
dcterms.dateAccepted2018-08-31en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record